Current role
Biotechnology · Healthcare
Board Member, Chairman
2026-07-27–present
Bill Lundberg
Board Member
Yarrow Bioscience, Inc. (YARW)Chairman
Yarrow Bioscience, Inc. (YARW)Equibles does not estimate personal net worth.
Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get YARW alertsAbout Bill Lundberg
Bill Lundberg is recorded as Board Member and Chairman at Yarrow Bioscience, Inc. (YARW) since July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Bill Lundberg was appointed Chair of the Board, effective July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Bill Lundberg was appointed Class II director, effective July 27, 2026. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Andrew Saik (CFO), Ilan Hadar (CFO) and 7 others.
“In connection with his appointment to the Board, Bill Lundberg was also appointed as Chair of the Board.”
“On July 27, 2026, the Board set its size at six members and appointed the following six individuals to the Board: Rebecca Frey, Mona Ashiya, Steven Hoerter, Bill Lundberg, Peter Silverman and William White.”
Affiliation history
-
Current
2026-07-27–present
-
Current
2026-07-27–present
Company network
Leadership on record at Yarrow Bioscience, Inc.
- Rebecca Frey CEO, Board Member
- Andrew Saik CFO
- Ilan Hadar CFO
- Tyler Zeronda CFO
- Rachael Alford COO
- Iain Stuart CTO
- David Domzalski Board Member
- Dr. Christine Borowski Board Member
- Mona Ashiya Board Member
- Mona Ashiya, Ph.D. Board Member